598 related articles for article (PubMed ID: 33572595)
1. Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine.
Supplitt S; Karpinski P; Sasiadek M; Laczmanska I
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572595
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization.
Sager M; Yeat NC; Pajaro-Van der Stadt S; Lin C; Ren Q; Lin J
Expert Rev Mol Diagn; 2015; 15(12):1589-603. PubMed ID: 26565429
[TBL] [Abstract][Full Text] [Related]
3. The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology.
Lin VTG; Yang ES
J Natl Cancer Inst; 2019 Oct; 111(10):1016-1022. PubMed ID: 31165154
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomics and solid tumors: The next frontier in precision cancer medicine.
Tsimberidou AM; Fountzilas E; Bleris L; Kurzrock R
Semin Cancer Biol; 2022 Sep; 84():50-59. PubMed ID: 32950605
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
6. RNA sequencing for research and diagnostics in clinical oncology.
Buzdin A; Sorokin M; Garazha A; Glusker A; Aleshin A; Poddubskaya E; Sekacheva M; Kim E; Gaifullin N; Giese A; Seryakov A; Rumiantsev P; Moshkovskii S; Moiseev A
Semin Cancer Biol; 2020 Feb; 60():311-323. PubMed ID: 31412295
[TBL] [Abstract][Full Text] [Related]
7. [Cancer: three eras of personalized medicine].
Jordan B
Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
[TBL] [Abstract][Full Text] [Related]
8. The emerging roles of NGS in clinical oncology and personalized medicine.
Hussen BM; Abdullah ST; Salihi A; Sabir DK; Sidiq KR; Rasul MF; Hidayat HJ; Ghafouri-Fard S; Taheri M; Jamali E
Pathol Res Pract; 2022 Feb; 230():153760. PubMed ID: 35033746
[TBL] [Abstract][Full Text] [Related]
9. Oncoproteomics: Trials and tribulations.
Zhou L; Li Q; Wang J; Huang C; Nice EC
Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
[TBL] [Abstract][Full Text] [Related]
10. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Kamel HFM; Al-Amodi HSAB
Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
[TBL] [Abstract][Full Text] [Related]
11. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
12. Cancer molecular markers: A guide to cancer detection and management.
Nair M; Sandhu SS; Sharma AK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):39-55. PubMed ID: 29428478
[TBL] [Abstract][Full Text] [Related]
13. Genomic profiling in oncology clinical practice.
Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
[TBL] [Abstract][Full Text] [Related]
14. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine.
Tian Q; Price ND; Hood L
J Intern Med; 2012 Feb; 271(2):111-21. PubMed ID: 22142401
[TBL] [Abstract][Full Text] [Related]
15. The Signature Program: Bringing the Protocol to the Patient.
Kang BP; Slosberg E; Snodgrass S; Lebedinsky C; Berry DA; Corless CL; Stein S; Salvado A
Clin Pharmacol Ther; 2015 Aug; 98(2):124-6. PubMed ID: 25810246
[TBL] [Abstract][Full Text] [Related]
16. [Personalized medicine in oncology].
Lörsch AM; Jung J; Lange S; Pfarr N; Mogler C; Illert AL
Pathologie (Heidelb); 2024 May; 45(3):180-189. PubMed ID: 38568256
[TBL] [Abstract][Full Text] [Related]
17. Application of personalized medicine to solid tumors: opportunities and challenges.
Ruiz C; Tolnay M; Bubendorf L
Swiss Med Wkly; 2012; 142():w13587. PubMed ID: 22714262
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing of cancer genomes: lessons learned.
Corrigan AE; Taylor R; Rallis KS
Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
[No Abstract] [Full Text] [Related]
19. Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology.
Valdes-Mora F; Handler K; Law AMK; Salomon R; Oakes SR; Ormandy CJ; Gallego-Ortega D
Front Immunol; 2018; 9():2582. PubMed ID: 30483257
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling for personalized cancer care.
Ashfaq R
Clin Exp Metastasis; 2012 Oct; 29(7):653-5. PubMed ID: 22678423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
